The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease - Results of the African American study of kidney disease and hypertension
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease - Results of the African American study of kidney disease and hypertension
复制标题
DOI:
10.1001/archinte.165.8.947
复制
发表时间:
2005-04-25
影响因子:
--
通讯作者:
Bakris, GL
中科院分区:
文献类型:
--
作者:
Lea, J;Greene, T;Bakris, GL
Background: The magnitude of proteinuria is associated with a graded increase in the risk of progression to end-stage renal disease and cardiovascular events. The objective of this study was to relate baseline and early changes in proteinuria and glomerular filtration rate (GFR) to long-term progression of hypertensive nondiabetic kidney disease.Methods: Post hoc analysis of a randomized 3 X 2 factorial trial. A total of 1094 African Americans with hypertensive renal disease (GFR, 20-65 mL/min per 1.73 m(2)) were followed up for a median of 3.8 years. Participants were randomized to a mean arterial pressure goal of 102 to 107 mm. Hg (usual) or 92 mm Hg or less (lower) and to initial treatment with a beta-blocker (metoprolol), an angiotensin-converting enzyme inhibitor (ramipril), or a dihydropyridine calcium channel blocker (amlodipine).Results: Baseline proteinuria and GFR predicted the rgateof GFR decline. For each 10-mL/min per 1. 73 m(2) lower baseline GFR, an associated mean +/- SE 0.38 +/- 0.08-mL/ min per 1. 73 m(2) per year greater mean GFR decline occurred, and for each 2-fold higher proteinuria level, a mean SE 0.54 0.05-mUmin per 1. 73 m(2) per year faster GFR decline was observed (P